Genmab | GEN - Ebit

Stock Price
1,714.50
Daily Change
12.00 0.70%
Monthly
-12.23%
Yearly
22.51%
Q1 Forecast
1,614.31

Genmab reported DKK432M in EBIT for its fiscal quarter ending in June of 2025.





Ebit Change Date
Agios Pharmaceuticals USD -121.58M 4.71M Dec/2025
Almirall EUR 30.23M 12.8M Dec/2025
Amarin USD -1.7M 8.47M Sep/2025
Amgen USD 3.96B 464M Dec/2025
argenx SE USD 371.14M 21.17M Dec/2025
AstraZeneca USD 2.97B 4.48B Dec/2025
Bayer EUR 1.11B 1.51B Dec/2025
BioMarin Pharmaceutical USD 198.39M 230.08M Dec/2025
Demant DKK 2.07B 201M Dec/2025
Exelixis USD 235.91M 20.45M Dec/2025
Fresenius Medical Care EUR 663M 213.06M Dec/2025
Galapagos EUR 780.56M 822.23M Dec/2025
Genmab DKK 432M 900.27M Jun/2025
GlaxoSmithKline GBP 1.44B 1.35B Dec/2025
GN Store Nord DKK 570M 230M Dec/2025
GRIFOLS EUR 352.11M 20.18M Sep/2025
Hikma Pharmaceutical USD 348M 31M Dec/2025
Insmed USD -249.71M 11.64M Dec/2025
Lonza CHF 673M 54M Jun/2025
Merck EUR 474M 738M Dec/2025
Novartis USD -9.19B 13.87B Jun/2025
Regeneron Pharmaceuticals USD 898.6M 211.3M Dec/2025
Roche Holding CHF 9.56B 2.1B Dec/2025
Sanofi EUR 1.7B 2.17B Dec/2025
UCB EUR 502M 168M Dec/2024